Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine
High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion.
Gespeichert in:
| Autor*in: |
Bassareo, P.P. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Umfang: |
4 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics - Abdel-Aziz, Tarek Ezzat ELSEVIER, 2014, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:90 ; year:2014 ; number:4 ; pages:173-176 ; extent:4 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.earlhumdev.2014.01.010 |
|---|
| Katalog-ID: |
ELV033961530 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV033961530 | ||
| 003 | DE-627 | ||
| 005 | 20230624001920.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.earlhumdev.2014.01.010 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014012000026.pica |
| 035 | |a (DE-627)ELV033961530 | ||
| 035 | |a (ELSEVIER)S0378-3782(14)00019-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 618.3/005 |q OCLC |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.45 |2 bkl | ||
| 100 | 1 | |a Bassareo, P.P. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine |
| 264 | 1 | |c 2014 | |
| 300 | |a 4 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. | ||
| 700 | 1 | |a Fanos, V. |4 oth | |
| 700 | 1 | |a Puddu, M. |4 oth | |
| 700 | 1 | |a Flore, G. |4 oth | |
| 700 | 1 | |a Mercuro, G. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Abdel-Aziz, Tarek Ezzat ELSEVIER |t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics |d 2014 |g Amsterdam [u.a.] |w (DE-627)ELV022803173 |
| 773 | 1 | 8 | |g volume:90 |g year:2014 |g number:4 |g pages:173-176 |g extent:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.earlhumdev.2014.01.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a GBV_ILN_350 | ||
| 936 | b | k | |a 44.45 |j Immunologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 90 |j 2014 |e 4 |h 173-176 |g 4 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
p b pb |
|---|---|
| matchkey_str |
bassareoppfanosvpuddumfloregmercurog:2014----:dacdnrueierwhetitoiascaewtrdcdxrtooa |
| hierarchy_sort_str |
2014 |
| bklnumber |
44.45 |
| publishDate |
2014 |
| allfields |
10.1016/j.earlhumdev.2014.01.010 doi GBVA2014012000026.pica (DE-627)ELV033961530 (ELSEVIER)S0378-3782(14)00019-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 618.3/005 OCLC 610 VZ 610 VZ 44.45 bkl Bassareo, P.P. verfasserin aut Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine 2014 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. Fanos, V. oth Puddu, M. oth Flore, G. oth Mercuro, G. oth Enthalten in Elsevier Science Abdel-Aziz, Tarek Ezzat ELSEVIER Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics 2014 Amsterdam [u.a.] (DE-627)ELV022803173 volume:90 year:2014 number:4 pages:173-176 extent:4 https://doi.org/10.1016/j.earlhumdev.2014.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_130 GBV_ILN_350 44.45 Immunologie VZ AR 90 2014 4 173-176 4 045F 610 |
| spelling |
10.1016/j.earlhumdev.2014.01.010 doi GBVA2014012000026.pica (DE-627)ELV033961530 (ELSEVIER)S0378-3782(14)00019-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 618.3/005 OCLC 610 VZ 610 VZ 44.45 bkl Bassareo, P.P. verfasserin aut Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine 2014 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. Fanos, V. oth Puddu, M. oth Flore, G. oth Mercuro, G. oth Enthalten in Elsevier Science Abdel-Aziz, Tarek Ezzat ELSEVIER Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics 2014 Amsterdam [u.a.] (DE-627)ELV022803173 volume:90 year:2014 number:4 pages:173-176 extent:4 https://doi.org/10.1016/j.earlhumdev.2014.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_130 GBV_ILN_350 44.45 Immunologie VZ AR 90 2014 4 173-176 4 045F 610 |
| allfields_unstemmed |
10.1016/j.earlhumdev.2014.01.010 doi GBVA2014012000026.pica (DE-627)ELV033961530 (ELSEVIER)S0378-3782(14)00019-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 618.3/005 OCLC 610 VZ 610 VZ 44.45 bkl Bassareo, P.P. verfasserin aut Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine 2014 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. Fanos, V. oth Puddu, M. oth Flore, G. oth Mercuro, G. oth Enthalten in Elsevier Science Abdel-Aziz, Tarek Ezzat ELSEVIER Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics 2014 Amsterdam [u.a.] (DE-627)ELV022803173 volume:90 year:2014 number:4 pages:173-176 extent:4 https://doi.org/10.1016/j.earlhumdev.2014.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_130 GBV_ILN_350 44.45 Immunologie VZ AR 90 2014 4 173-176 4 045F 610 |
| allfieldsGer |
10.1016/j.earlhumdev.2014.01.010 doi GBVA2014012000026.pica (DE-627)ELV033961530 (ELSEVIER)S0378-3782(14)00019-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 618.3/005 OCLC 610 VZ 610 VZ 44.45 bkl Bassareo, P.P. verfasserin aut Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine 2014 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. Fanos, V. oth Puddu, M. oth Flore, G. oth Mercuro, G. oth Enthalten in Elsevier Science Abdel-Aziz, Tarek Ezzat ELSEVIER Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics 2014 Amsterdam [u.a.] (DE-627)ELV022803173 volume:90 year:2014 number:4 pages:173-176 extent:4 https://doi.org/10.1016/j.earlhumdev.2014.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_130 GBV_ILN_350 44.45 Immunologie VZ AR 90 2014 4 173-176 4 045F 610 |
| allfieldsSound |
10.1016/j.earlhumdev.2014.01.010 doi GBVA2014012000026.pica (DE-627)ELV033961530 (ELSEVIER)S0378-3782(14)00019-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 618.3/005 OCLC 610 VZ 610 VZ 44.45 bkl Bassareo, P.P. verfasserin aut Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine 2014 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. Fanos, V. oth Puddu, M. oth Flore, G. oth Mercuro, G. oth Enthalten in Elsevier Science Abdel-Aziz, Tarek Ezzat ELSEVIER Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics 2014 Amsterdam [u.a.] (DE-627)ELV022803173 volume:90 year:2014 number:4 pages:173-176 extent:4 https://doi.org/10.1016/j.earlhumdev.2014.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_130 GBV_ILN_350 44.45 Immunologie VZ AR 90 2014 4 173-176 4 045F 610 |
| language |
English |
| source |
Enthalten in Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics Amsterdam [u.a.] volume:90 year:2014 number:4 pages:173-176 extent:4 |
| sourceStr |
Enthalten in Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics Amsterdam [u.a.] volume:90 year:2014 number:4 pages:173-176 extent:4 |
| format_phy_str_mv |
Article |
| bklname |
Immunologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics |
| authorswithroles_txt_mv |
Bassareo, P.P. @@aut@@ Fanos, V. @@oth@@ Puddu, M. @@oth@@ Flore, G. @@oth@@ Mercuro, G. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV022803173 |
| dewey-sort |
3610 |
| id |
ELV033961530 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV033961530</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624001920.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.earlhumdev.2014.01.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014012000026.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV033961530</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-3782(14)00019-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">618.3/005</subfield><subfield code="q">OCLC</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bassareo, P.P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fanos, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Puddu, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flore, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mercuro, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Abdel-Aziz, Tarek Ezzat ELSEVIER</subfield><subfield code="t">Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics</subfield><subfield code="d">2014</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV022803173</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:90</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:173-176</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.earlhumdev.2014.01.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_350</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">90</subfield><subfield code="j">2014</subfield><subfield code="e">4</subfield><subfield code="h">173-176</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Bassareo, P.P. |
| spellingShingle |
Bassareo, P.P. ddc 610 ddc 618.3/005 bkl 44.45 Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine |
| authorStr |
Bassareo, P.P. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV022803173 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 618 - Gynecology, obstetrics, pediatrics & geriatrics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 618.3/005 OCLC 610 VZ 44.45 bkl Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine |
| topic |
ddc 610 ddc 618.3/005 bkl 44.45 |
| topic_unstemmed |
ddc 610 ddc 618.3/005 bkl 44.45 |
| topic_browse |
ddc 610 ddc 618.3/005 bkl 44.45 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
v f vf m p mp g f gf g m gm |
| hierarchy_parent_title |
Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics |
| hierarchy_parent_id |
ELV022803173 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV022803173 |
| title |
Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine |
| ctrlnum |
(DE-627)ELV033961530 (ELSEVIER)S0378-3782(14)00019-X |
| title_full |
Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine |
| author_sort |
Bassareo, P.P. |
| journal |
Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics |
| journalStr |
Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
173 |
| author_browse |
Bassareo, P.P. |
| container_volume |
90 |
| physical |
4 |
| class |
610 610 DE-600 618.3/005 OCLC 610 VZ 44.45 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Bassareo, P.P. |
| doi_str_mv |
10.1016/j.earlhumdev.2014.01.010 |
| dewey-full |
610 618.3/005 |
| title_sort |
advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine |
| title_auth |
Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine |
| abstract |
High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. |
| abstractGer |
High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. |
| abstract_unstemmed |
High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_130 GBV_ILN_350 |
| container_issue |
4 |
| title_short |
Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine |
| url |
https://doi.org/10.1016/j.earlhumdev.2014.01.010 |
| remote_bool |
true |
| author2 |
Fanos, V. Puddu, M. Flore, G. Mercuro, G. |
| author2Str |
Fanos, V. Puddu, M. Flore, G. Mercuro, G. |
| ppnlink |
ELV022803173 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1016/j.earlhumdev.2014.01.010 |
| up_date |
2024-07-06T19:54:52.334Z |
| _version_ |
1803860775885864960 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV033961530</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624001920.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.earlhumdev.2014.01.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014012000026.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV033961530</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-3782(14)00019-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">618.3/005</subfield><subfield code="q">OCLC</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bassareo, P.P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">High blood levels of asymmetric dimethylarginine (ADMA) are associated with future development of adverse cardiovascular events. The ADMA/symmetric dimethylarginine (SDMA) ratio is a marker of ADMA catabolism, with a high ADMA/SDMA ratio being suggestive of reduced ADMA excretion.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fanos, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Puddu, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flore, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mercuro, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Abdel-Aziz, Tarek Ezzat ELSEVIER</subfield><subfield code="t">Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics</subfield><subfield code="d">2014</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV022803173</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:90</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:173-176</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.earlhumdev.2014.01.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_350</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">90</subfield><subfield code="j">2014</subfield><subfield code="e">4</subfield><subfield code="h">173-176</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.402316 |